Status:
COMPLETED
Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis Application
Lead Sponsor:
Vantive Health LLC
Collaborating Sponsors:
Gambro Dialysatoren GmbH
Baxter Healthcare Corporation
Conditions:
Hemodialysis
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The clinical study aims at providing data on antimicrobial efficiency and a supposed additional preventive effect on catheter-related infections of a catheter with antibacterial surface coating in com...
Detailed Description
Central venous catheters are increasingly used to provide long-term venous access, e.g. after failure of the primary arteriovenous fistula, and they are the first choice in case of an acute need for e...
Eligibility Criteria
Inclusion
- central venous catheter placement
- Need for extracorporeal renal replacement therapy (acute and chronic renal failure)
- Anticipated duration of dialysis therapy less than or equal to 30 days
- Age between 18 and 85 years
- Written informed consent
Exclusion
- Known Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) infection
- Known pregnancy
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT00621114
Start Date
August 1 2007
End Date
July 1 2009
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitaetsklinikum Tuebingen
Tübingen, Germany, 72076